These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8811228)

  • 1. Funding of coronary angioplasty in public hospitals.
    Eccleston DS; Eisenberg MJ
    Aust N Z J Med; 1996 Jun; 26(3):430-1. PubMed ID: 8811228
    [No Abstract]   [Full Text] [Related]  

  • 2. Funding of coronary angioplasty and coronary stenting in public hospitals.
    Harper RW
    Aust N Z J Med; 1996 Feb; 26(1):3-4. PubMed ID: 8775519
    [No Abstract]   [Full Text] [Related]  

  • 3. Funding of coronary angioplasty in public hospitals.
    Batey RG
    Aust N Z J Med; 1996 Jun; 26(3):430. PubMed ID: 8811227
    [No Abstract]   [Full Text] [Related]  

  • 4. Costs, charges and revenues of elective coronary angioplasty and stenting: the public versus the private system.
    Harper RW; Sampson KD; See PL; Kealey JL; Meredith IT
    Med J Aust; 2000 Sep; 173(6):296-300. PubMed ID: 11061398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The euros and sense of stents: do we get value for money?
    Annemans L
    J Cardiovasc Med (Hagerstown); 2011 Dec; 12(12):878-82. PubMed ID: 22025203
    [No Abstract]   [Full Text] [Related]  

  • 6. Economics and cost-effectiveness in evaluating the value of cardiovascular therapies. Coronary stents: an industry perspective.
    Marshall PR
    Am Heart J; 1999 May; 137(5):S138-41. PubMed ID: 10220617
    [No Abstract]   [Full Text] [Related]  

  • 7. Should use of intracoronary stents during percutaneous revascularisation be restricted?
    Palmer N; Fort S; Starkey I; Shaw T; Northridge D
    Lancet; 1998 Feb; 351(9100):416-7. PubMed ID: 9482299
    [No Abstract]   [Full Text] [Related]  

  • 8. Economics and cost-effectiveness in evaluating the value of cardiovascular therapies. Coronary stents: a health system perspective.
    Ahmad M
    Am Heart J; 1999 May; 137(5):S142-4. PubMed ID: 10220618
    [No Abstract]   [Full Text] [Related]  

  • 9. Economics and cost-effectiveness in evaluating the value of cardiovascular therapies. Evaluation of the cost-effectiveness of coronary stenting: a societal perspective.
    Cohen DJ
    Am Heart J; 1999 May; 137(5):S133-7. PubMed ID: 10220616
    [No Abstract]   [Full Text] [Related]  

  • 10. Cost-effective analysis of primary infarct-artery stenting versus optimal primary angioplasty (the Florence Randomized Elective Stenting in Acute Coronary Occlusions [FRESCO] trial).
    Antoniucci D; Valenti R; Moschi G; Santoro GM; Bolognese L; Trapani M; Fazzini PF
    Am J Cardiol; 2000 May; 85(10):1247-9. PubMed ID: 10802011
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug-eluting stents: more dollars than sense?
    Garg S; Eisenberg MJ
    JACC Cardiovasc Interv; 2009 Dec; 2(12):1188-9. PubMed ID: 20129544
    [No Abstract]   [Full Text] [Related]  

  • 12. Economics of sirolimus-eluting stents: drug-eluting stents have really arrived.
    Weintraub WS
    Circulation; 2004 Aug; 110(5):472-4. PubMed ID: 15289386
    [No Abstract]   [Full Text] [Related]  

  • 13. Costs of interventional cardiac procedures.
    Mark DB
    J Interv Cardiol; 1994 Aug; 7(4):369-78. PubMed ID: 10151067
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cost analysis of percutaneous coronary intervention and coronary artery bypass grafting in Japan and USA].
    Chino M; Sasaki T
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():632-7. PubMed ID: 12735043
    [No Abstract]   [Full Text] [Related]  

  • 15. Coronary artery bypass surgery is still cost-effective: using calibrated models to update clinical trials.
    Weinstein MC
    Am J Med; 2003 Oct; 115(5):410-1. PubMed ID: 14553880
    [No Abstract]   [Full Text] [Related]  

  • 16. Long term outcome and cost-effectiveness of stenting versus balloon angioplasty for acute myocardial infarction.
    Suryapranata H; Ottervanger JP; Nibbering E; van 't Hof AW; Hoorntje JC; de Boer MJ; Al MJ; Zijlstra F
    Heart; 2001 Jun; 85(6):667-71. PubMed ID: 11359749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-eluting coronary stents: faith and hope, but no charity.
    Knudtson ML
    CMAJ; 2007 Jan; 176(2):195-6. PubMed ID: 17179218
    [No Abstract]   [Full Text] [Related]  

  • 18. Cost-effectiveness of bypass surgery versus stenting in patients with multivessel coronary artery disease.
    Yock CA; Boothroyd DB; Owens DK; Garber AM; Hlatky MA
    Am J Med; 2003 Oct; 115(5):382-9. PubMed ID: 14553874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute and long-term cost implications of coronary stenting.
    Peterson ED; Cowper PA; DeLong ER; Zidar JP; Stack RS; Mark DB
    J Am Coll Cardiol; 1999 May; 33(6):1610-8. PubMed ID: 10334432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PCI and stable coronary heart disease--COURAGE to change our minds?
    Kakafika AI; Mikhailidis DP; Wierzbicki AS; Karagiannis A; Athyros VG
    Curr Vasc Pharmacol; 2007 Jul; 5(3):173-4. PubMed ID: 17627560
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.